Beam Therapeutics Inc (NASDAQ:BEAM)
| 30.61 Delayed Data As of Mar 31 |  +0.46 / +1.53%Today’s Change | 27.77 Today|||52-Week Range 73.27 | -21.73% Year-to-Date |
Latest BEAM News | Press Releases
No recent news for Beam Therapeutics Inc.
Today’s Trading
| Previous close | 30.15 |
| Today’s open | 30.11 |
| Day’s range | 30.11 - 31.18 |
| Volume | 23,945 |
| Average volume (3 months) | 869,146 |
| Market cap | $2.2B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +28.45% |
| Earnings growth (this year) | -29.35% |
| Earnings growth (next 5 years) | -19.20% |
| Revenue growth (last year) | +17.51% |
| P/E ratio | NM |
| Price/Sales | 44.95 |
| Price/Book | 2.97 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | May 8, 2023 |
| EPS forecast (this quarter) | -$1.32 |
| Annual revenue (last year) | $60.9M |
| Annual profit (last year) | -$289.1M |
| Net profit margin | -474.54% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
